Skip to main content
SpringerLink
Log in

Glabridin Relaxes Vascular Smooth Muscles by Activating BKCa Channels and Inhibiting Phosphodiesterase in Human Saphenous Vein

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The aim of the current study was to investigate the pharmacological activity of glabridin on the isolated human saphenous vein (SV) and explore the underlying mechanisms. Samples of patients’ SVs were removed during bypass surgery, and 4-mm lengths of the vessels were placed in Krebs solution at +4°C and hung in an isolated organ bath to assess their contraction/relaxation responses. The contraction/relaxation responses were recorded to observe if the cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) pathway mediates the relaxant effect of glabridin after treatment with blockers like ODQ (a guanylate cyclase inhibitor), KT5823 (a PKG inhibitor), isobutylmethylxanthine [IBMX, a phosphodiesterase (PDE) inhibitor], and cantharidin [Cant, a myosin light-chain phosphatase (MLCP) inhibitor]. Moreover, nitric oxide (NO), cGMP, and PKG levels in SV tissues were determined by ELISA after incubation with glabridin, N(ω)-nitro-L-arginine methyl ester (L-Name, a NO synthetase inhibitor), phenylephrine (PE), ODQ, IBMX, and KT5823. The results showed that glabridin relaxed the vascular smooth muscle of human SV pretreated with PE in a dose-dependent manner, which was independent of the endothelium. The vasorelaxant effect of glabridin was only inhibited by iberiotoxin (IbTX), Cant, and KT5823. Glabridin increased cGMP and PKG levels in SV homogenates, whereas it did not alter the NO level. The enhancing effects of cGMP and PKG levels by glabridin were abolished by ODQ and KT5823. In conclusion, glabridin has a vasorelaxant effect, which is associated with the activation of BKCa channels and inhibition of PDE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hussain H, Green IR, Shamraiz U, et al. Therapeutic potential of glycyrrhetinic acids: a patent review (2010–2017). Expert Opin Ther Pat, 2018,28(5):383–398

    Article  CAS  Google Scholar 

  2. Singh P, Singh D, Goel RK. Protective effect on phenytoin-induced cognition deficit in pentylenetetrazol kindled mice: A repertoire of Glycyrrhiza glabra flavonoid antioxidants. Pharm Biol, 2016,54(7):1209–1218

    CAS  PubMed  Google Scholar 

  3. Alwan AM, Nesrullah Z, Faraj E. Study the Effect of Ethanolic Extract of Glycyrrhiza glabra on Pathogenic Bacteria. Int J Curr Microbiol Applide Sci, 2015,4(5): 473–484

    CAS  Google Scholar 

  4. Yang R, Yuan BC, Ma YS, et al. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol, 2017,55(1):5–18

    Article  CAS  Google Scholar 

  5. Kang JS, Yoon YD, Cho IJ, et al. Glabridin, an Isoflavan from Licorice Root, Inhibits Inducible Nitric-Oxide Synthase Expression and Improves Survival of Mice in Experimental Model of Septic Shock. J Pharmacol Exp Ther, 2004,312(3):1187–1194

    Article  Google Scholar 

  6. Yokota T, Nishio H, Kubota Y, et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment cell Res, 1998,11(6):355–361

    Article  CAS  Google Scholar 

  7. Parlar A, Arslan SO, Çam SA. Glabridin alleviates inflammation and nociception in rodents by activating BKCa channels and reducing NO levels. Biol Pharm Bull, 2020,43(5):884–897

    Article  CAS  Google Scholar 

  8. Kang MR, Park KH, Oh SJ, et al. Cardiovascular protective effect of glabridin: Implications in LDL oxidation and inflammation. Int Immunopharmacol, 2015,29:914–918

    Article  CAS  Google Scholar 

  9. Tsantoulas C. Emerging potassium channel targets for the treatment of pain. Curr Opin Support Palliat Care, 2015,9:147–154

    Article  Google Scholar 

  10. Chen SR, Cai YQ, Pan HL. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J Neurochem, 2009,110(1):352–362

    Article  CAS  Google Scholar 

  11. Lu R, Lukowski R, Sausbier M, et al. BKCa channels expressed in sensory neurons modulate inflammatory pain in mice. Pain, 2014,155(3):556–565

    Article  CAS  Google Scholar 

  12. Chanda D, Prieto-Lloret J, Singh A, et al. Glabridin-induced vasorelaxation: Evidence for a role of BKCa channels and cyclic GMP. Life Sci, 2016,165:26–34

    Article  CAS  Google Scholar 

  13. Lee MS, Park SJ, Kandzari DE, et al. Saphenous vein graft intervention. JACC Cardiovasc Interv, 2011,4:831–843

    Article  Google Scholar 

  14. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation, 1998,97:916–931

    Article  CAS  Google Scholar 

  15. Pal R, Chaudhary MJ, Tiwari PC, et al. Pharmacological and biochemical studies on protective effects of mangiferin and its interaction with nitric oxide (NO) modulators in adjuvant-induced changes in arthritic parameters, inflammatory, and oxidative biomarkers in rats. Inflammopharmacology, 2019,27(2):291–299

    Article  CAS  Google Scholar 

  16. Gupta VK, Fatima A, Faridi U, et al. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol, 2008,116(2):377–380

    Article  Google Scholar 

  17. El-Ashmawy NE, Khedr NF, El-Bahrawy HA, et al. Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis. Inflammopharmacology, 2018,26(2):551–559

    Article  CAS  Google Scholar 

  18. Pereira ASP, Banegas-Luna AJ, Peña-García J, et al. Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening. Molecules, 2019,24(2):4030

    Article  CAS  Google Scholar 

  19. Fuhrman B, Buch S, Vaya J, et al. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr, 1997,66(2):267–275

    Article  CAS  Google Scholar 

  20. Bolton TB, Lang RJ, Takewaki T. Mechanisms of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J Physiol, 1984,351(1):549–572

    Article  CAS  Google Scholar 

  21. Knock GA, Smirnov SV, Aaronson PI. Voltage-gated K+ currents in freshly isolated myocytes of the pregnant human myometrium. J Physiol, 1999,518(3):769–781

    Article  CAS  Google Scholar 

  22. Liu J, Liu H, Li Y, et al. Cross regulation between cGMP-dependent protein kinase and Akt in vasodilatation of porcine pulmonary artery. J Cardiovasc Pharmacol, 2014,64(5):452–459

    Article  CAS  Google Scholar 

  23. White RE, Kryman JP, El-Mowafy AM, et al. cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells. Circ Res, 2000,86(8):897–905

    Article  CAS  Google Scholar 

  24. Carrier GO, Fuchs LC, Winecoff AP, et al. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol — Hear Circ Physiol, 1997,273(1 Pt2):76–84

    Article  Google Scholar 

  25. Kyle BD, Hurst S, Swayze RD, et al. Specific phosphorylation sites underlie the stimulation of a large conductance, Ca2+-activated K+ channel by cGMP-dependent protein kinase. FASEB J, 2013,27(5):2027–2038

    Article  CAS  Google Scholar 

  26. Bae H, Lim I. Effects of nitric oxide on large-conductance Ca2+-activated K+ currents in human cardiac fibroblasts through PKA and PKG-related pathways. Clin Exp Pharmacol Physiol, 2017,44(11):1116–1124

    Article  CAS  Google Scholar 

  27. Dantas BPV, Ribeiro TP, Assis VL, et al. Vasorelaxation induced by a new naphthoquinone-oxime is mediated by NO-sGC-cGMP pathway. Molecules, 2014,19(7):9773–9785

    Article  Google Scholar 

  28. Li H, Shin SE, Seo MS, et al. The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels. Life Sci, 2018,197:46–55

    Article  CAS  Google Scholar 

  29. Wang P, Wu P, Myers JG, et al. Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases. Life Sci, 2001,68(17):1977–1987

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Surgery, Faculty of Medicine, University of Adiyaman, Adiyaman, 02040, Turkey

    Cengiz Güven

  2. Department of Pharmacology, Faculty of Medicine, University of Adiyaman, Adiyaman, 02040, Turkey

    Ali Parlar

Authors
  1. Cengiz Güven
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Parlar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Parlar.

Additional information

Conflict of Interest Statement

The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Güven, C., Parlar, A. Glabridin Relaxes Vascular Smooth Muscles by Activating BKCa Channels and Inhibiting Phosphodiesterase in Human Saphenous Vein. CURR MED SCI 41, 381–389 (2021). https://doi.org/10.1007/s11596-021-2358-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-021-2358-6

Key words

Search

Navigation